Stephens & Co. Reiterates Overweight on Guardant Health, Maintains $44 Price Target
Portfolio Pulse from Benzinga Newsdesk
Stephens & Co. analyst Mason Carrico has reiterated an Overweight rating on Guardant Health (NASDAQ:GH) and maintained a $44 price target.
May 24, 2024 | 3:42 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Stephens & Co. analyst Mason Carrico has reiterated an Overweight rating on Guardant Health and maintained a $44 price target, indicating continued confidence in the company's stock performance.
The reiteration of an Overweight rating and the maintenance of a $44 price target by a reputable analyst suggests positive sentiment and confidence in Guardant Health's stock performance. This is likely to have a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100